A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

Multiple candidate vaccines to prevent COVID-19 have entered large-scale phase 3 placebo-controlled randomized clinical trials, and several have demonstrated substantial short-term efficacy. At some point after demonstration of substantial efficacy, placebo recipients should be offered the efficacio...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Ann Intern Med
Główni autorzy: Follmann, Dean, Fintzi, Jonathan, Fay, Michael P., Janes, Holly E., Baden, Lindsey R., El Sahly, Hana M., Fleming, Thomas R., Mehrotra, Devan V., Carpp, Lindsay N., Juraska, Michal, Benkeser, David, Donnell, Deborah, Fong, Youyi, Han, Shu, Hirsch, Ian, Huang, Ying, Huang, Yunda, Hyrien, Ollivier, Luedtke, Alex, Carone, Marco, Nason, Martha, Vandebosch, An, Zhou, Honghong, Cho, Iksung, Gabriel, Erin, Kublin, James G., Cohen, Myron S., Corey, Lawrence, Gilbert, Peter B., Neuzil, Kathleen M.
Format: Artigo
Język:Inglês
Wydane: American College of Physicians 2021
Hasła przedmiotowe:
Research and Reporting Methods
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099035/
https://ncbi.nlm.nih.gov/pubmed/33844575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-8149
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy